**2.5 Case report Edward**

**Focus:** insulin pump implementation in 2014 led to post-initial remission until 2018, which was followed by an increase in HbA1c, body mass, and IU/d needed.

**History:** Edward (today 46 y/o) was diagnosed with T1D at 27 years of age, in 2014. The diagnosis was made based on the abrupt onset of clinical symptoms such as polydipsia, polyuria, fatigue, and eventually loss of body mass (2 kg/month). He was given insulin in the form of Novopen (insulin aspart and detemir). After 6 weeks, an insulin pump, Paradigm Veo (**Figure 11**), was implemented while doing intensive selfmonitoring of plasma glucose (SMPG) using glucometer Contour plus. Initially, Edward was skeptical about the insulin pump; due to his physical activity and sports, he was not sure if the pump would be an obstruction during his activities (**Table 5**). After education, when seeing the last parameters (**Figures 12** and **13**), he agreed to try MiniMed 780G.

**Figure 11.** *Paradigm Veo 554 and a subcutaneous cannula on the front of the thigh.*

